Hainan Poly Pharm: Announcement on Progress of Investigation and Risk Warning Regarding Filing Matters.
Hainan Poly Pharm: Notice of convening the 2023 Annual Shareholders' Meeting
Hainan Poly Pharm: In 2021, Hainan Poly Pharm Co., Ltd. issued convertible bonds to unspecified entities, and a tracking rating report will be available in 2024.
Hainan Poly Pharm: Legal opinion for the second extraordinary shareholders meeting in 2024.
Hainan Poly Pharm: Announcement of resolution of the Second Extraordinary Shareholders' Meeting in 2024.
Hainan Poly Pharm: Correction and Notice of the Second Extraordinary Shareholders' Meeting in 2024
Hainan Poly Pharm: Opinions on the Review of Qualifications for Independent Director Candidates
Hainan Poly Pharm: Notice Regarding the Holding of the Second Extraordinary Shareholders' Meeting in 2024.
Hainan Poly Pharm: Commitment letter on attending training for independent directors and obtaining the certificate of independent directors qualification.
Hainan Poly Pharm: Announcement on Resignation of Independent Director and Election of Independent Director
Hainan Poly Pharm: Haitong Securities Co., Ltd.'s summary report on the sponsorship of Hainan Poly Pharma Co., Ltd.'s issuance of convertible corporate bonds to unspecified targets and listing.
Hainan Poly Pharm: Announcement regarding not lowering the conversion price of Prudential convertible bonds to equity.
Hainan Poly Pharm: Risk Warning Notice
Hainan Poly Pharm: Announcement regarding the receipt of the Notice of Filing and the related risk warning from the China Securities Regulatory Commission.
Hainan Poly Pharm: Special explanation about the plan not to distribute profits in 2023.
Hainan Poly Pharm: The board of directors' audit committee's report on the performance evaluation and supervision of the accounting firm during the year 2023.
Hainan Poly Pharm: Announcement Regarding the Recognition of Asset Impairment Provisions in 2023
Hainan Poly Pharm: Disclosure Announcement for the First Quarter Report of 2024.
Hainan Poly Pharm: Announcement on the Resumption of Stock Conversion of PuLi Convertible Bonds.
Hainan Poly Pharm: 2023 Annual Internal Control Self-Evaluation Report
No Data